Series I： on the CCP's Organ Transplant Industry Chain

Hello everyone, welcome to Jingyuan Finance. China's first organ transplant company, Shanghai Jiangeng Medical Technology Co., Ltd., is about to go public on the Growth Enterprise Market (GEM) in China. It is generally believed that organ transplantation is a small market, with official figures showing that the number of surgeries performed each year does not exceed 20,000 cases. How can an organ transplant company become big enough and enter the capital market for financing? Today, let's explore China's organ transplant industry.